0001104659-24-069783.txt : 20240607
0001104659-24-069783.hdr.sgml : 20240607
20240607192416
ACCESSION NUMBER: 0001104659-24-069783
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240607
FILED AS OF DATE: 20240607
DATE AS OF CHANGE: 20240607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tursi James Patrick
CENTRAL INDEX KEY: 0001527710
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37809
FILM NUMBER: 241031163
MAIL ADDRESS:
STREET 1: 106 ASHLEY COURT
CITY: MOORESTOWN
STATE: NJ
ZIP: 08057
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NeuroBo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001638287
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 472389984
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 545 CONCORD AVENUE
STREET 2: SUITE 210
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
BUSINESS PHONE: (857) 702-9600
MAIL ADDRESS:
STREET 1: 545 CONCORD AVENUE
STREET 2: SUITE 210
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
FORMER COMPANY:
FORMER CONFORMED NAME: Gemphire Therapeutics Inc.
DATE OF NAME CHANGE: 20150331
4
1
tm2416741-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-06-07
0
0001638287
NeuroBo Pharmaceuticals, Inc.
NRBO
0001527710
Tursi James Patrick
C/O NEUROBO PHARMACEUTICALS, INC.
545 CONCORD AVENUE, SUITE 210
CAMBRIDGE,
MA
02138
1
0
0
0
0
Common Stock
2024-06-07
4
A
0
5051
0
A
9072
D
Represents a grant of restricted stock units issued to the Reporting Person under the Issuer's 2022 Equity Incentive Plan, which vests on the earlier of June 7, 2025 or the day immediately prior to the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continuing service on the applicable vesting date.
The total number of securities beneficially owned
has been adjusted to reflect the Issuer's completion
of a 1-for-8 reverse stock split on December 20,
2023.
/s/ Phillip D. Torrence, by Power of Attorney
2024-06-07